LumiraDx gains on more job cuts
** Shares of diagnostics co LumiraDx Ltd LMDX.O rise 16.4%
to $0.64
** Co further reduces 40% of its global workforce, after
laying off 200 employees, equivalent to 16% of its global
workforce, in last December
** Releases cost restructuring program that is to result in
about $36 mln in annualised savings
** Says it continues to focus on operating cost reductions
** Including session gains, stock has lost about 38.9% YTD
(Reporting by Vaibhav Sadhamta in Bengaluru)
((Vaibhav.sadhamta@thomsonreuters.com))
Recent news on LumiraDx
See all newsBrief: LumiraDx Announces Its Securities Will Be Suspended From Trading On Nasdaq At The Open Of Business On January 9Th
Roche to buy part of LumiraDx diagnostics platform for $295 million
Brief: LumiraDx- Under Terms Of Certain Loan Agreement, Dated March 23, 2021, The Waiver Period Has Expired As Of Today
Brief: LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
Brief: Willard L. Umphrey Reports 10.31% Stake In Lumiradx Limited As Of Dec 22- SEC Filing